Key Insights

Highlights

Success Rate

100% trial completion (above average)

Treatment Research

10 treatments under study, led by Anterior Approach

Research Leaders

5 sponsors active, led by Istituto Ortopedico Rizzoli

Clinical Risk Assessment

Based on trial outcomes

Moderate Risk

Score: 50/100

Termination Rate

0.0%

0 terminated out of 4 trials

Success Rate

100.0%

+13.4% vs benchmark

Late-Stage Pipeline

0%

0 trials in Phase 3/4

Results Transparency

0%

0 of 1 completed with results

Key Signals

100% success

Data Visualizations

Phase Distribution

2Total
Not Applicable (2)

Trial Status

Completed1
Unknown1
Not Yet Recruiting1
Active Not Recruiting1

Trial Success Rate

100.0%

Benchmark: 86.6%

Based on 1 completed trials

Clinical Trials (4)

Showing 4 of 4 trials
NCT06924567Not Yet RecruitingPrimary

Radiographic Stability of Hip Prosthesis Prior to Revision Surgery

NCT05204797Not ApplicableActive Not RecruitingPrimary

Efficacy of Robot-assisted Technique vs Conventional Technique in Preventing Early Micromobilisation After UKA

NCT04773054CompletedPrimary

Identification of Infections in Hip Arthroplasty Loosening.

NCT05508958Not ApplicableUnknownPrimary

Cup Revisions Through Anterior or Posterolateral Approach: an RCT

Showing all 4 trials

Research Network

Common Treatments

  • Anterior Approach1
  • Robotassisted Uka1
  • Characterization Of Oral Microbiota1
  • Histological Analysis Of Periprosthetic Tissue1
  • Characterization Of Tissue Microbiota1

Active Sponsors

  • Istituto Ortopedico Rizzoli2
  • Sectra AB, Sweden1
  • Reinier Haga Orthopedisch Centrum1
  • Georgios Tsikandylakis, MD PhD1
  • Smith & Nephew, Inc.1

Top Investigators

Related Conditions

  • Hip Arthropathy1

Activity Timeline